Mitochondrial dysfunction and intracellular calcium dysregulation in ALS
about
The Dual Function of Reactive Oxygen/Nitrogen Species in Bioenergetics and Cell Death: The Role of ATP SynthaseA comprehensive review of amyotrophic lateral sclerosisAn Overview of Potential Targets for Treating Amyotrophic Lateral Sclerosis and Huntington's DiseaseMicroglial cell dysregulation in brain aging and neurodegenerationCalcium dysregulation links ALS defective proteins and motor neuron selective vulnerabilityExploring new pathways of neurodegeneration in ALS: the role of mitochondria quality controlModulation of astrocytic mitochondrial function by dichloroacetate improves survival and motor performance in inherited amyotrophic lateral sclerosisElevated PGC-1α activity sustains mitochondrial biogenesis and muscle function without extending survival in a mouse model of inherited ALSAbnormal mitochondrial transport and morphology are common pathological denominators in SOD1 and TDP43 ALS mouse models.Role of mitochondria in mutant SOD1 linked amyotrophic lateral sclerosisEffects of natural antioxidants in neurodegenerative disease.Oxidative stress, mitochondrial damage and neurodegenerative diseasesGlutaredoxin 2 prevents aggregation of mutant SOD1 in mitochondria and abolishes its toxicity.Neuroprotection for amyotrophic lateral sclerosis: role of stem cells, growth factors, and gene therapy.Autophagy of mitochondria: a promising therapeutic target for neurodegenerative disease.Mechanisms, models and biomarkers in amyotrophic lateral sclerosisLong-term blocking of calcium channels in mdx mice results in differential effects on heart and skeletal muscleCaveolin-1 and mitochondrial SOD2 (MnSOD) function as tumor suppressors in the stromal microenvironment: a new genetically tractable model for human cancer associated fibroblastsAssessing mitochondrial dysfunction in cells.Repetitive nerve stimulation transiently opens the mitochondrial permeability transition pore in motor nerve terminals of symptomatic mutant SOD1 miceElevated mRNA-levels of distinct mitochondrial and plasma membrane Ca(2+) transporters in individual hypoglossal motor neurons of endstage SOD1 transgenic mice.Mitochondrial membrane potential is regulated by vimentin intermediate filamentsSeeking homeostasis: temporal trends in respiration, oxidation, and calcium in SOD1 G93A Amyotrophic Lateral Sclerosis mice.Mitochondria as a therapeutic target for aging and neurodegenerative diseases.The Mitochondrial Permeability Transition Pore: Channel Formation by F-ATP Synthase, Integration in Signal Transduction, and Role in Pathophysiology.Role of calcium and mitochondria in MeHg-mediated cytotoxicity.The mitochondrial calcium regulator cyclophilin D is an essential component of oestrogen-mediated neuroprotection in amyotrophic lateral sclerosisState of the field: An informatics-based systematic review of the SOD1-G93A amyotrophic lateral sclerosis transgenic mouse model.Mitochondrial dynamics and bioenergetic dysfunction is associated with synaptic alterations in mutant SOD1 motor neurons.Genetic variability of the gene cluster CALHM 1-3 in sporadic Creutzfeldt-Jakob disease.Biology and Metabolism of Sepsis: Innate Immunity, Bioenergetics, and AutophagyA screening-based platform for the assessment of cellular respiration in Caenorhabditis elegans.Abnormal intracellular calcium signaling and SNARE-dependent exocytosis contributes to SOD1G93A astrocyte-mediated toxicity in amyotrophic lateral sclerosis.SOD1 and TDP-43 animal models of amyotrophic lateral sclerosis: recent advances in understanding disease toward the development of clinical treatments.Understanding ALS: new therapeutic approaches.Mitochondrial dysfunction in psychiatric and neurological diseases: cause(s), consequence(s), and implications of antioxidant therapy.Mitochondrial Disorders May Mimic Amyotrophic Lateral Sclerosis at Onset.Selective vulnerability of motoneuron and perturbed mitochondrial calcium homeostasis in amyotrophic lateral sclerosis: implications for motoneurons specific calcium dysregulation.Targeting mitochondrial metal dyshomeostasis for the treatment of neurodegeneration.Ultrastructural features of aberrant glial cells isolated from the spinal cord of paralytic rats expressing the amyotrophic lateral sclerosis-linked SOD1G93A mutation.
P2860
Q26749074-D9268FAC-8B78-48A3-9C2D-74678F77D5FFQ26775401-A95E1B5D-076A-4827-9CDA-B81C338AFB82Q26796027-FAA9AFC1-DEDE-4DE7-8C0C-AE7F044C43EFQ26800212-5551793F-1CC8-4CE6-A7E3-75BA48741C82Q28084373-5C4ACACD-8D44-44AE-A1D1-3C7A958A7978Q28391199-931E81EB-90A9-46AE-97E2-F90A25679394Q28482111-0421C08F-C7BE-4F33-8C16-87EB7D4C4D89Q30534614-3E66874E-D60D-479A-8B94-62303B17BC81Q30572264-A0545F66-C9CE-4664-A1AC-1B87FD0AF3A7Q33819255-41F5204F-BF77-4D52-AF7A-133EBA0611D0Q34030539-014A4646-7AE0-4F9C-8044-A50D2928BF62Q34094532-2D74EF5E-38C0-47F1-B856-5D89C91C0F9FQ34137069-30E2F49B-8F30-4899-8A91-40F3719CB43CQ34222849-5FD27146-2CBB-4C58-8189-1632D1FFE2CDQ34287719-975FB300-9D99-4DB5-93B8-CA0BA88D4ABFQ34344992-CD49FD4A-EC62-45E0-86E1-3D6C4DEE4D4AQ34469185-4E28CB54-6B3A-4E68-A8E6-5369901401A8Q34616660-4935A590-FCF9-400A-87F9-EA38FAD6BE32Q34793639-4A5925CD-44C4-4AD2-A4D2-67EBE0AA716AQ34819311-DAA9E07C-4AF0-4E83-9FCD-6352FCE6DA91Q35469175-FE2B6EEB-E4A7-4857-90F0-19188F7AF701Q35576479-61788FC7-5E28-4E8A-A453-3C75CDBF63F6Q35802837-2D008E47-F9C6-4AE3-B1A4-D6CEB5B979D3Q35807409-DE1BEA5E-E154-4135-BF18-3E24BD36865BQ36146320-CA5A1634-2B5A-4AC0-AD57-CE4D68946C0AQ36183970-69934716-E045-4AEB-8CA9-36CDF65B4F1EQ36218731-30D1F484-ECB8-452C-B217-9A09043E35ADQ36494315-26006474-FF53-4B7B-89FA-0F59B18D2C3BQ36593996-9AF7E5CC-1915-4FF2-84C3-A6DAB814A1BBQ36719069-EC908708-B182-4709-A0AF-731F21D3E27BQ36925803-CB056EFF-AE31-4C6B-B113-A22031F0CACBQ37292765-A14F7DE2-C3DA-4425-B394-4746058CD6EFQ37555038-E49D362C-3DA9-4248-8B9F-66A1AC2B5E18Q37894600-C7E23F41-AFBC-4888-AEE1-405FD8C824A9Q38065343-DB7B2180-8D47-4506-9341-79337CCB43DDQ38086474-605FF9D2-15B5-4DA8-B92A-A38DC45AC501Q38288851-E2219FB8-1EE9-444D-B9EB-15DF4B0D8436Q38521756-9C0792D0-44A2-4C6F-A94F-DDDA40E40E49Q38570991-4D9CFAFA-7DDD-498A-86A5-6CE3BEC8AE94Q38597154-B52B5264-BE80-499C-872C-D2DF2ECAECDE
P2860
Mitochondrial dysfunction and intracellular calcium dysregulation in ALS
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Mitochondrial dysfunction and intracellular calcium dysregulation in ALS
@ast
Mitochondrial dysfunction and intracellular calcium dysregulation in ALS
@en
Mitochondrial dysfunction and intracellular calcium dysregulation in ALS
@nl
type
label
Mitochondrial dysfunction and intracellular calcium dysregulation in ALS
@ast
Mitochondrial dysfunction and intracellular calcium dysregulation in ALS
@en
Mitochondrial dysfunction and intracellular calcium dysregulation in ALS
@nl
prefLabel
Mitochondrial dysfunction and intracellular calcium dysregulation in ALS
@ast
Mitochondrial dysfunction and intracellular calcium dysregulation in ALS
@en
Mitochondrial dysfunction and intracellular calcium dysregulation in ALS
@nl
P2860
P1476
Mitochondrial dysfunction and intracellular calcium dysregulation in ALS
@en
P2093
Giovanni Manfredi
Hibiki Kawamata
P2860
P304
P356
10.1016/J.MAD.2010.05.003
P577
2010-05-20T00:00:00Z